Adaptimmune Therapeutics plc (MUN:473A)
Germany · Delayed Price · Currency is EUR 0.0125
0.00 (0.00%)
At close: May 21, 2026
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €6.02 million as of August 26, 2026. Its market cap has decreased by -53.21% in one year.
Market Cap
6.02M
Enterprise Value
-4.17M
Revenue
5.05M
Ranking
n/a
PE Ratio
0.28
Stock Price
€0.01
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 6.02M, a decrease of -99.44%. That is a compound annual growth rate of -36.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 5.68M | -3.26% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| Vidac Pharma Holding | 21.53M |
| co.don AG | 360.77K |
| Paion AG | 342.42K |
| bioXXmed AG | 231.09K |